Previous 10 | Next 10 |
home / stock / rvv:cc / rvv:cc news
Revive Therapeutics Ltd - Ordinary Shares (RVV:CNX) is expected to report for quarter end 2023-06-30
TORONTO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, t...
TORONTO, July 28, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, to...
TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, to...
TORONTO, May 02, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, tod...
Purchased MDMA supply from PharmAla Biotech for upcoming IND-enabling studies Finalizing product and clinical development plans for upcoming studies and potential commercial opportunities TORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive...
TORONTO, March 28, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, i...
TORONTO, March 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, a...
FDA recommends additional revised primary symptom-based endpoints Revive to provide amended statistical analysis plan to support unblinding of the data to potentially provide evidence of efficacy TORONTO, March 08, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive&...
VANCOUVER, British Columbia, Feb. 06, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce that it has signed on to act as exclusive supplier of both GMP LaNeo MDMA and Engineering MDMA to Revive Therapeutics (CSE:RVV) (OTCQB: RVVTF)...
News, Short Squeeze, Breakout and More Instantly...
Revive Therapeutics Ltd - Ordinary Shares Company Name:
RVV:CC Stock Symbol:
CNQC Market:
A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) rose 0.2% to $78.44 on volume of 4,819,630 shares iShares Core Canadian Short Term Corporate Bond Index ETF (XSH) rose 0.1% to $18.65 on volume of 3,547,470 shares Corus Entertainment Inc. Class B Non-Voting Shar...
A look at the top 10 most actives in Canada Canadian Natural Resources Limited (CNQ) rose 2.3% to $50.13 on volume of 15,553,477 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 11.5% to $2.93 on volume of 12,773,153 shares Toronto-Dominion Bank (The) (TD) rose 1.2% to $78.2...
A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) rose 0.3% to $76.13 on volume of 16,847,005 shares Canadian Natural Resources Limited (CNQ) fell 1.5% to $48.33 on volume of 7,922,140 shares TC Energy Corporation (TRP) rose 0.1% to $51.11 on volume of 7,293,869...